Anteris Technologies Global Corp. (AVR) vs Cytek Biosciences, Inc. (CTKB)
A side-by-side comparison of Anteris Technologies Global Corp. and Cytek Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVR
Anteris Technologies Global Corp.
$7.09HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
CTKB
Cytek Biosciences, Inc.
$5.55HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — AVR vs CTKB
growth of $100 · dividends reinvested · last 2yAVR +34.8% (+16.1%/yr)CTKB -1.9% (-1.0%/yr)AVR compounded faster over this window
AVR CTKB
AVR vs CTKB: by the numbers
- •CTKB is the larger company ($717M vs $689M market cap).
- •Both run net losses; CTKB's is the smaller (-38.98% vs -4619.67% net margin).
- •CTKB grew revenue faster over the past five years (13.37% vs -18.92% CAGR).
Metrics side by side
Valuation
| Metric | AVR | CTKB |
|---|---|---|
| P/S ratio | 307.27 | 3.47 |
| P/B ratio | 2.74 | 2.23 |
Profitability
| Metric | AVR | CTKB |
|---|---|---|
| Gross margin | -16.57% | 53.23% |
| Operating margin | -4908.21% | -21.60% |
| Net margin | -4619.67% | -38.98% |
| ROE | -41.20% | -25.03% |
| ROIC | -41.63% | -12.00% |
Growth (annualized)
| Metric | AVR | CTKB |
|---|---|---|
| Revenue CAGR (5Y) | -18.92% | 13.37% |
| Total return CAGR (5Y) | N/A | -23.16% |
Frequently asked
- Which has grown faster, AVR or CTKB?
- Over the past five years, CTKB grew revenue faster — AVR at a -18.92% CAGR versus CTKB at 13.37%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.